Crossref
journal-article
American Chemical Society (ACS)
Bioconjugate Chemistry (316)
References
44
Referenced
112
{'key': 'bc060174rb00001/bc060174rb00001_1', 'volume-title': 'Boron neutron capture therapy of cancer:\u2009 current status and future prospects. Clin. Cancer Res. 11, 3987−4002', 'author': 'Barth R. F.', 'year': '2005'}
/ Boron neutron capture therapy of cancer: current status and future prospects. Clin. Cancer Res. 11, 3987−4002 by Barth R. F. (2005){'key': 'bc060174rb00002/bc060174rb00002_1', 'first-page': '210', 'volume': '62', 'author': 'Barth R. F.', 'year': '2003', 'journal-title': 'J. Neurooncol.'}
/ J. Neurooncol. by Barth R. F. (2003){'key': 'bc060174rb00003/bc060174rb00003_1', 'volume-title': 'Proceedings of the eleventh world congress on neutron capture therapy. Appl. Radiat. Isot. 61', 'author': 'Zamenhof R. G.', 'year': '2004'}
/ Proceedings of the eleventh world congress on neutron capture therapy. Appl. Radiat. Isot. 61 by Zamenhof R. G. (2004){'key': 'bc060174rb00004/bc060174rb00004_1', 'volume-title': 'Boron containing macromolecules and nanovehicles as delivery agents for neutron capture therapy. Anticancer Agents Med. Chem. 6, 167−84', 'author': 'Wu G.', 'year': '2006'}
/ Boron containing macromolecules and nanovehicles as delivery agents for neutron capture therapy. Anticancer Agents Med. Chem. 6, 167−84 by Wu G. (2006){'key': 'bc060174rb00005/bc060174rb00005_1', 'first-page': '181', 'volume': '6', 'author': 'Vicente M. G. H.', 'year': '2006', 'journal-title': 'Anticancer Agents Med. Chem.'}
/ Anticancer Agents Med. Chem. by Vicente M. G. H. (2006){'key': 'bc060174rb00006/bc060174rb00006_1', 'volume-title': 'Boron-containing folate receptor-targeted liposomes as potential delivery agents for neutron capture therapy. Bioconjugate Chem. 13, 435−42', 'author': 'Pan X. Q.', 'year': '2002'}
/ Boron-containing folate receptor-targeted liposomes as potential delivery agents for neutron capture therapy. Bioconjugate Chem. 13, 435−42 by Pan X. Q. (2002){'key': 'bc060174rb00007/bc060174rb00007_1', 'volume-title': 'Folate receptor-mediated liposomal delivery of a lipophilic boron agent to tumor cells in vitro for neutron capture therapy. Pharm. Res. 19, 1502−8', 'author': 'Sudimack J. J.', 'year': '2002'}
/ Folate receptor-mediated liposomal delivery of a lipophilic boron agent to tumor cells in vitro for neutron capture therapy. Pharm. Res. 19, 1502−8 by Sudimack J. J. (2002){'key': 'bc060174rb00008/bc060174rb00008_1', 'first-page': '25', 'volume': '74', 'author': 'Jain R. K.', 'year': '2001', 'journal-title': 'J. Controlled Release'}
/ J. Controlled Release by Jain R. K. (2001){'key': 'bc060174rb00009/bc060174rb00009_1', 'first-page': '17', 'volume': '1', 'author': 'Pan X.', 'year': '2004', 'journal-title': 'Exp. Opin. Drug Delivery'}
/ Exp. Opin. Drug Delivery by Pan X. (2004){'key': 'bc060174rb00010/bc060174rb00010_1', 'volume-title': 'Ligand-targeted liposomal anticancer drugs. Prog. Lipid Res. 42, 439−62', 'author': 'Sapra P.', 'year': '2003'}
/ Ligand-targeted liposomal anticancer drugs. Prog. Lipid Res. 42, 439−62 by Sapra P. (2003){'key': 'bc060174rb00011/bc060174rb00011_1', 'volume-title': 'Cell-specific drug transfer from liposomes bearing monoclonal-antibodies. Nature (London) 293, 226−228', 'author': 'Leserman L. D.', 'year': '1981'}
/ Cell-specific drug transfer from liposomes bearing monoclonal-antibodies. Nature (London) 293, 226−228 by Leserman L. D. (1981)10.1021/bi962148u
/ Biochemistry by Kirpotin D. (1997)-
Xu, L., Pirollo, K. F., and Chang, E. H. (1997) Transferrin-liposome-mediated p53 sensitization of squamous cell carcinoma of the head and neck to radiation in vitro.Hum. Gene Ther.8, 467−75.
(
10.1089/hum.1997.8.4-467
) {'key': 'bc060174rb00014/bc060174rb00014_1', 'volume-title': 'Development of EGF-conjugated liposomes for targeted delivery of boronated DNA-binding agents. Bioconjugate Chem. 13, 737−43', 'author': 'Bohl Kullberg E.', 'year': '2002'}
/ Development of EGF-conjugated liposomes for targeted delivery of boronated DNA-binding agents. Bioconjugate Chem. 13, 737−43 by Bohl Kullberg E. (2002)10.1016/S0378-5173(02)00682-8
/ Int. J. Pharm. by Janssen A. P. (2003){'key': 'bc060174rb00016/bc060174rb00016_1', 'volume-title': 'Targeting liposomes to tumor endothelial cells for neutron capture therapy. Appl. Radiat. Isot. 61, 963−7', 'author': 'Koning G. A.', 'year': '2004'}
/ Targeting liposomes to tumor endothelial cells for neutron capture therapy. Appl. Radiat. Isot. 61, 963−7 by Koning G. A. (2004){'key': 'bc060174rb00017/bc060174rb00017_1', 'volume': '148', 'author': 'Sauter G.', 'year': '1996', 'journal-title': 'Am. J. Pathol.'}
/ Am. J. Pathol. by Sauter G. (1996)10.1002/ijc.2910620206
/ Int. J. Cancer by Schwechheimer K. (1995){'key': 'bc060174rb00019/bc060174rb00019_1', 'volume-title': 'Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas. Cancer Res. 62, 3159−66', 'author': 'Barth R. F.', 'year': '2002'}
/ Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas. Cancer Res. 62, 3159−66 by Barth R. F. (2002)-
Wu, G., Barth, R. F., Yang, W., Chatterjee, M., Tjarks, W., Ciesielski, M. J., and Fenstermaker, R. A. (2004) Site-specific conjugation of boron-containing dendrimers to anti-EGF receptor monoclonal antibody cetuximab (IMC-C225) and its evaluation as a potential delivery agent for neutron capture therapy.Bioconjugate Chem.15, 185−94.
(
10.1021/bc0341674
) {'key': 'bc060174rb00021/bc060174rb00021_1', 'volume-title': 'Development of a syngeneic rat brain tumor model expressing EGFRvIII and its use for molecular targeting studies with monoclonal antibody L8A4. Clin. Cancer Res. 11, 341−50', 'author': 'Yang W.', 'year': '2005'}
/ Development of a syngeneic rat brain tumor model expressing EGFRvIII and its use for molecular targeting studies with monoclonal antibody L8A4. Clin. Cancer Res. 11, 341−50 by Yang W. (2005){'key': 'bc060174rb00022/bc060174rb00022_1', 'volume-title': 'Neutron capture therapy of epidermal growth factor (+) gliomas using boronated cetuximab (IMC-C225) as a delivery agent. Appl. Radiat. Isot. 61, 899−903', 'author': 'Barth R. F.', 'year': '2004'}
/ Neutron capture therapy of epidermal growth factor (+) gliomas using boronated cetuximab (IMC-C225) as a delivery agent. Appl. Radiat. Isot. 61, 899−903 by Barth R. F. (2004){'key': 'bc060174rb00023/bc060174rb00023_1', 'volume-title': 'Molecular targeting and treatment of EGFRvIII-positive gliomas using boronated monoclonal antibody L8A4. Clin. Cancer Res. 12, 3792−802', 'author': 'Yang W.', 'year': '2006'}
/ Molecular targeting and treatment of EGFRvIII-positive gliomas using boronated monoclonal antibody L8A4. Clin. Cancer Res. 12, 3792−802 by Yang W. (2006){'key': 'bc060174rb00024/bc060174rb00024_1', 'volume-title': 'Proc. Natl. Acad. Sci. U.S.A. 91', 'author': 'Bobo R. H.', 'year': '1994'}
/ Proc. Natl. Acad. Sci. U.S.A. 91 by Bobo R. H. (1994){'key': 'bc060174rb00025/bc060174rb00025_1', 'volume-title': 'Immunoliposome targeting to CD4+ cells in human blood. Cancer Detect. Prev. 14, 383−90', 'author': 'Phillips N. C.', 'year': '1990'}
/ Immunoliposome targeting to CD4+ cells in human blood. Cancer Detect. Prev. 14, 383−90 by Phillips N. C. (1990)10.1042/bj20031034
/ Biochem. J. by Schnyder A. (2004){'key': 'bc060174rb00027/bc060174rb00027_1', 'volume-title': 'Immunoliposomes for cancer treatment. Adv. Pharmacol. 40, 399−435', 'author': 'Park J. W.', 'year': '1997'}
/ Immunoliposomes for cancer treatment. Adv. Pharmacol. 40, 399−435 by Park J. W. (1997)10.1016/0168-3659(95)00149-2
/ J. Controlled Release by Zalipsky S. (1996)10.1016/S0014-5793(99)01320-4
/ FEBS Lett. by Ishida T. (1999){'key': 'bc060174rb00030/bc060174rb00030_1', 'volume': '1513', 'author': 'Iden D. L.', 'year': '2001', 'journal-title': 'Biochim. Biophys. Acta'}
/ Biochim. Biophys. Acta by Iden D. L. (2001){'key': 'bc060174rb00031/bc060174rb00031_1', 'volume': '269', 'author': 'Lee R. J.', 'year': '1994', 'journal-title': 'J. Biol. Chem.'}
/ J. Biol. Chem. by Lee R. J. (1994){'key': 'bc060174rb00032/bc060174rb00032_1', 'volume': '10', 'author': 'Guo W. J.', 'year': '2000', 'journal-title': 'J. Liposome Res.'}
/ J. Liposome Res. by Guo W. J. (2000)10.1023/A:1005805203044
/ J. Neurooncol. by Barth R. F. (1998){'key': 'bc060174rb00034/bc060174rb00034_1', 'first-page': '23', 'volume': '557', 'author': 'Olson F.', 'year': '1979', 'journal-title': 'Biochim. Biophs. Acta'}
/ Biochim. Biophs. Acta by Olson F. (1979){'key': 'bc060174rb00035/bc060174rb00035_1', 'volume-title': 'Microdetermination of phosphorus. Anal. Chem. 28, 1756−58', 'author': 'Chen P. S.', 'year': '1956'}
/ Microdetermination of phosphorus. Anal. Chem. 28, 1756−58 by Chen P. S. (1956){'key': 'bc060174rb00036/bc060174rb00036_1', 'volume-title': 'A rapid and sensitive for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248−254', 'author': 'Bradford M. M.', 'year': '1974'}
/ A rapid and sensitive for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248−254 by Bradford M. M. (1974){'key': 'bc060174rb00037/bc060174rb00037_1', 'volume-title': 'Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells. Cancer Res. 63, 3154−61', 'author': 'Mamot C.', 'year': '2003'}
/ Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells. Cancer Res. 63, 3154−61 by Mamot C. (2003){'key': 'bc060174rb00038/bc060174rb00038_1', 'volume-title': 'Endocytosis and intracellular fate of liposomes using pyranine as a probe. Biochemistry 29, 4929−39', 'author': 'Straubinger R. M.', 'year': '1990'}
/ Endocytosis and intracellular fate of liposomes using pyranine as a probe. Biochemistry 29, 4929−39 by Straubinger R. M. (1990){'key': 'bc060174rb00039/bc060174rb00039_1', 'volume': '8', 'author': 'Bhadra D.', 'year': '2005', 'journal-title': 'J. Pharm. Pharm. Sci.'}
/ J. Pharm. Pharm. Sci. by Bhadra D. (2005)10.1002/jps.20098
/ J. Pharm. Sci. by Nobs L. (2004)10.1016/S0006-3495(98)78026-9
/ Biophys. J. by Beugin S. (1998)10.1016/S0009-3084(01)00178-5
/ Chem. Phys. Lipids by Carrion C. (2001){'key': 'bc060174rb00043/bc060174rb00043_1', 'volume-title': 'Cure of Fisher rats bearing radioresistant F98 glioma treated with cis-platinum and irradiated with monochromatic synchrotron X-rays. Cancer Res. 64, 2317−23', 'author': 'Biston M. C.', 'year': '2004'}
/ Cure of Fisher rats bearing radioresistant F98 glioma treated with cis-platinum and irradiated with monochromatic synchrotron X-rays. Cancer Res. 64, 2317−23 by Biston M. C. (2004){'key': 'bc060174rb00044/bc060174rb00044_1', 'volume': '64', 'author': 'Adam J. F.', 'year': '2006', 'journal-title': 'Int. J. Radiat. Oncol. Biol. Phys.'}
/ Int. J. Radiat. Oncol. Biol. Phys. by Adam J. F. (2006)
Dates
Type | When |
---|---|
Created | 18 years, 8 months ago (Dec. 21, 2006, 8:03 a.m.) |
Deposited | 2 years, 5 months ago (March 13, 2023, 9:52 p.m.) |
Indexed | 3 months ago (May 30, 2025, 11:27 a.m.) |
Issued | 18 years, 8 months ago (Dec. 21, 2006) |
Published | 18 years, 8 months ago (Dec. 21, 2006) |
Published Online | 18 years, 8 months ago (Dec. 21, 2006) |
Published Print | 18 years, 8 months ago (Jan. 1, 2007) |
@article{Pan_2006, title={Synthesis of Cetuximab-Immunoliposomes via a Cholesterol-Based Membrane Anchor for Targeting of EGFR}, volume={18}, ISSN={1520-4812}, url={http://dx.doi.org/10.1021/bc060174r}, DOI={10.1021/bc060174r}, number={1}, journal={Bioconjugate Chemistry}, publisher={American Chemical Society (ACS)}, author={Pan, Xiaogang and Wu, Gong and Yang, Weiliang and Barth, Rolf F. and Tjarks, Werner and Lee, Robert J.}, year={2006}, month=dec, pages={101–108} }